Bcel stock forecast.

Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Keurig Dr Pepper Inc have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 27.00. The ...Find real-time VCEL - Vericel Corp stock quotes, company profile, news and forecasts from CNN Business.Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …

Atreca, Inc. Class A Common Stock (BCEL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

1 analysts 33.33% Hold 2 analysts 66.67% Sell 0 analysts 0% Strong Sell 0 analysts 0% Be the first to know when Wall Street analysts revise their BCEL stock forecasts and price …

HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.

The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...

During trading Thursday, 8 stocks traded to a 52-week high, while 130 stocks bottomed out at new 52-week lows. The S&P 500 is down 1.45% so far today while the Dow is down 1.05%, the Nasdaq is down 2....

The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ...The Wall Street analysts predict Outperform for BCEL. See at a glance whether NasdaqGS:BCEL will rise in the future. Company; Stock analysis; Earnings Calendars ... 4 years of reliable Atreca stock forecast. The Wall Street analysts predict Outperform for BCEL. See at a glance whether NasdaqGS:BCEL will rise in the future. …BCEL Stock 12 Months Forecast $2.00 (790.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Atreca in the last 3 months. The average price target …BCEL vs Biotech Stocks. Ticker Inst. % Insider % Net Insider (L12M) Net Insider (L3M) BCEL: 31.32%: 21.52%: Net Selling: Net Selling: IMNN: 4.39%: 92.03%: FRES: 0.00%: 0.00%: ... Top Performing Analysts Stock Screener Stock Forecast Trending Stocks Strong Buy Stocks Highest Earnings Stocks Best Dividend Paying Stocks Statistics …VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.

Li Auto Inc - ADR Stock Forecast, LI stock price prediction. Price target in 14 days: 44.695 USD. The best long-term & short-term Li Auto Inc - ADR share price ...Dec 1, 2023 · Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks.Earnings announcement* for BCEL: Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. BCEL has a "high" Earnings Quality Ranking (EQR) for the 5th ...ENDRA Life Sciences Inc. 0.97. +0.01. +1.0417%. ARTH. Get Atreca Inc (BCEL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.Price target. 3.25 0.00 0.00%. The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — and a min estimate of —.

BCEL Stock 12 Months Forecast. $2.00. (790.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Atreca in the last 3 months. The average price target is $2.00 with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 790.87% change from the last price of $0.22.

Find the latest Patterson-UTI Energy, Inc. (PTEN) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,509.52%. …Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for BCEL. The average twelve-month price prediction for Atreca is $10.75 with a high price target of $25.00 and a low price target of $4.00. Learn more on BCEL's analyst rating history.Dec 1, 2023 · 3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price. BCEL BCEL Atreca Inc - Ordinary Shares - Class A 2,464 Watch Alerts $0.223 $0.0092 (4.30%) Today $0.23 0.0035 (1.57%) After Hours About Feed News Sentiment Earnings …October 13, 2023. At the time of writing, Atreca Inc [BCEL] stock is trading at $0.38, up 61.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BCEL shares have gain 66.93% over the last week, with a monthly amount glided 11.79%, and seem to be holding up well over a long-time horizon.See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Atreca, Inc. (BCEL) stock forecast and price target. Find the latest Atreca, Inc. BCEL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Nov 29, 2023 · Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%.

We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...

Performance Outlook. Short Term. 2W - 6W. Mid Term. 6W - 9M. Long Term. 9M+ Previous Close: 0.2197 ... Stock Falls 37%. Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101 ...BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ...Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ... Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response.The average Terran Orbital stock price prediction forecasts a potential upside of 731.23% from the current LLAP share price of $0.79. What is LLAP's forecast return on equity (ROE) for 2023-2026? (NYSE: LLAP) forecast ROE is N/A, which is considered weak.11.85 %. The 3 Wall Street analysts offering Atreca stock forecast in the last 6 months have average price target of $9.0 with a high forecast of $25.0 and a low forecast of $1.0. The average Atreca stock forecast represents a 3729.79% increase from the last price of $0.234999999403953. From AI system, total return is 2366.52% from 4098 forecasts.The BCEL shares have gain 66.93% over the last week, with a monthly amount glided 11.79%, and seem to be holding At the time of writing, Atreca Inc [BCEL] stock is trading at $0.38, up 61.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

$0.220 +0.0047 (+2.19%) At Close: Nov 30, 2023 Real-time prices appear during market hours U.S. markets are closed | Score: -1.37 Strong Sell Hold Strong Buy …See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).Atreca Inc - Class A Stock Chart and Share Price Forecast, Short-Term "BCEL" Stock Prediction for Next Days and Weeks Walletinvestor.com Atreca Inc - Class A (BCEL) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Instagram:https://instagram. personal loan for retired personkennedy halves worthyield municipal bondsftec dividend Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ... msn.com - August 11 at 5:24 PM. Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring. finance.yahoo.com - August 11 at 12:47 AM. Atreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20. msn.com - August 2 at 12:44 PM. Atreca Approaches A Major Go/No-Go Decision. stock cobaltscanner.in stock Aug 7, 2023 · BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%. During that period the price should oscillate between -9.61% and +7.63%. lithium ion battery companies stock Zacks' 7 Strongest Buys for December, 2023. Our experts just released their predictions for 7 stocks likely to climb the highest in the next 30-90 days. Chosen from the market-doubling list of ...Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...